UCB in Slough, United Kingdom, is seeking a Biological Project Leader in Drug Substance (DS NBE DSPL) to drive development from preclinical stages through Phase 3. You will lead integrated Drug Substance strategies, coordinate multidisciplinary teams, and ensure scientific excellence, quality and regulatory readiness across the lifecycle.
In this role you will work with Drug Substance Biological Process Sciences, Clinical Manufacturing, regulatory and quality specialists, and external partners
#J-18808-LjbffrBiological Drug Substance Project Leader — Phase 3 Strategy in Slough employer: UCB
UCB is an excellent employer that fosters a collaborative and innovative work culture, particularly in the vibrant field of immunology. With a strong focus on employee growth, UCB offers numerous opportunities for professional development and engagement in cutting-edge research projects. Located in a dynamic environment, employees benefit from a supportive atmosphere that encourages creativity and teamwork, making it a rewarding place to contribute to meaningful advancements in patient solutions.
